烦忧 发表于 2025-3-23 11:49:26

http://reply.papertrans.cn/2/113/11221/11221-11.png

RECUR 发表于 2025-3-23 14:40:05

Submitted on: 16 December 2001.
Revised on: 31 January 2002.
Accepted on: 05 March 2002.

___________________Hepatic Oncology---FUTURE MEDICINE LTD

flimsy 发表于 2025-3-23 20:00:49

Submitted on: 28 March 2008.
Revised on: 27 April 2008.
Accepted on: 22 May 2008.

___________________Hepatic Oncology---FUTURE MEDICINE LTD

dilute 发表于 2025-3-23 23:46:47

http://reply.papertrans.cn/2/113/11221/11221-14.png

铁砧 发表于 2025-3-24 06:20:36

http://reply.papertrans.cn/2/113/11221/11221-15.png

实施生效 发表于 2025-3-24 08:20:10

http://reply.papertrans.cn/2/113/11221/11221-16.png

搬运工 发表于 2025-3-24 10:54:10

http://reply.papertrans.cn/2/113/11221/11221-17.png

刺耳的声音 发表于 2025-3-24 17:53:49

Submitted on: 05 January 2010.
Revised on: 01 May 2010.
Accepted on: 15 June 2010.

___________________Hepatic Oncology---FUTURE MEDICINE LTD

减少 发表于 2025-3-24 21:38:51

http://reply.papertrans.cn/2/113/11221/11221-19.png

xanthelasma 发表于 2025-3-25 00:17:40

http://reply.papertrans.cn/2/113/11221/11221-20.png
页: 1 [2] 3 4
查看完整版本: ESCI期刊Hepatic Oncology 2024/2025影响因子:1.241 (HEPAT ONCOL) (2045-0923). (ONCOLOGY)(肿瘤学)Emerging Sources Citation Index